false
OasisLMS
Login
Catalog
Kidney Week 2026 Early Program On-Demand - Autosom ...
Management of Liver Complications in ADPKD
Management of Liver Complications in ADPKD
Back to course
[Please upgrade your browser to play this video content]
Video Transcription
Video Summary
Dr. Mary Hogan reviewed liver complications in ADPKD and related polycystic liver disease, emphasizing that liver severity can differ greatly from kidney disease. Most liver cysts remain asymptomatic, but a minority—particularly women—develop substantial enlargement and symptoms. Imaging is central to assessing cyst burden, disease pattern, complications, and suitability for procedures; collaboration among nephrologists, radiologists, hepatologists, and surgeons is essential.<br /><br />Management depends on symptoms and anatomy. Options include observation, aspiration and sclerotherapy for selected large cysts, somatostatin analogues to reduce liver growth and symptoms, and liver resection when disease is localized and enough healthy liver remains. Severe, diffuse, refractory disease may require transplant evaluation. Tolvaptan does not treat liver growth, though combined treatment approaches may benefit selected patients with both substantial kidney and liver disease.<br /><br />Acute pain may signal cyst hemorrhage or rupture; fever and inflammation raise concern for cyst infection, often requiring prolonged antibiotics and sometimes drainage. Clinicians should also watch for biliary or venous obstruction, malnutrition, and frailty. Treatment response should be followed with symptom measures and repeat imaging, while accounting for medication side effects and access challenges.
Asset Caption
Marie C. Hogan, MD, PhD, FASN
Meta Tag
Speaker
Marie Hogan
Keywords
ADPKD
polycystic liver disease
liver cysts
imaging assessment
somatostatin analogues
aspiration sclerotherapy
liver resection
transplant evaluation
cyst infection
×
Please select your language
1
English